All Programs

Use the tool below to view all available Global Oncology Academy Series

MinuteCE®
Mastering EGFR Testing and Targeted Therapy in Advanced NSCLC: From Molecular Profiling to Multidisciplinary Mastery
1.00 credit 10 episodes
- Professor ByoungChul Cho
- Keith Kerr, BSc, MB ChB
- Natasha B. Leighl, MD, MMSc
1.00 credit 10 episodes
Novel Therapies in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Novel Therapies in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
MinuteCE®
Novel Therapies in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
1.25 program credits
- Stephen Liu, MD
- Joshua K. Sabari, MD
- Susan Scott, MD
1.25 program credits
Applications of Emerging Data in Resectable NSCLC
Applications of Emerging Data in Resectable NSCLC
MinuteCE®
Applications of Emerging Data in Resectable NSCLC
1.25 program credits
- Stephen Liu, MD
- Joshua K. Sabari, MD
- Susan Scott, MD
1.25 program credits
Finding the Optimal Treatment for EGFR-mutated Metastatic NSCLC
Finding the Optimal Treatment for EGFR-mutated Metastatic NSCLC
MinuteCE®
Finding the Optimal Treatment for EGFR-mutated Metastatic NSCLC
1.25 program credits
- Stephen Liu, MD
- Joshua K. Sabari, MD
- Susan Scott, MD
1.25 program credits
HER2-Driven Strategies in Metastatic NSCLC
HER2-Driven Strategies in Metastatic NSCLC
MinuteCE®
HER2-Driven Strategies in Metastatic NSCLC
1.25 program credits
- Stephen Liu, MD
- Joshua K. Sabari, MD
- Susan Scott, MD
1.25 program credits
MET and Other Emerging Targets in Metastatic NSCLC
MET and Other Emerging Targets in Metastatic NSCLC
MinuteCE®
MET and Other Emerging Targets in Metastatic NSCLC
1.25 program credits
- Stephen Liu, MD
- Joshua K. Sabari, MD
- Susan Scott, MD
1.25 program credits
Emerging Therapeutic Developments in Non-Targetable Metastatic NSCLC
Emerging Therapeutic Developments in Non-Targetable Metastatic NSCLC
MinuteCE®
Emerging Therapeutic Developments in Non-Targetable Metastatic NSCLC
1.25 program credits
- Stephen Liu, MD
- Joshua K. Sabari, MD
- Susan Scott, MD
1.25 program credits
Guidelines in Flux – Making Sense of the Shifting Local Standards 
Guidelines in Flux – Making Sense of the Shifting Local Standards 
MinuteCE®
Guidelines in Flux – Making Sense of the Shifting Local Standards 
1.00 program credit
- Professor ByoungChul Cho
- Keith Kerr, BSc, MB ChB
- Natasha B. Leighl, MD, MMSc
1.00 program credit
The Precision Playbook – Optimizing Treatment Selection and Sequencing 
The Precision Playbook – Optimizing Treatment Selection and Sequencing 
MinuteCE®
The Precision Playbook – Optimizing Treatment Selection and Sequencing 
1.00 program credit
- Professor ByoungChul Cho
- Keith Kerr, BSc, MB ChB
- Natasha B. Leighl, MD, MMSc
1.00 program credit
The Treatment Symphony – Coordinating Multidisciplinary Care for Best Outcomes
The Treatment Symphony – Coordinating Multidisciplinary Care for Best Outcomes
MinuteCE®
The Treatment Symphony – Coordinating Multidisciplinary Care for Best Outcomes
1.00 program credit
- Professor ByoungChul Cho
- Keith Kerr, BSc, MB ChB
- Natasha B. Leighl, MD, MMSc
1.00 program credit
Under the Skin: Revolutionizing Oncology Drug Delivery
Under the Skin: Revolutionizing Oncology Drug Delivery
MinuteCE®
Under the Skin: Revolutionizing Oncology Drug Delivery
1.00 program credit
- Professor ByoungChul Cho
- Keith Kerr, BSc, MB ChB
- Natasha B. Leighl, MD, MMSc
1.00 program credit
The Safety Balancing Act – Mastering Adverse Event Management 
The Safety Balancing Act – Mastering Adverse Event Management 
MinuteCE®
The Safety Balancing Act – Mastering Adverse Event Management 
1.00 program credit
- Professor ByoungChul Cho
- Keith Kerr, BSc, MB ChB
- Natasha B. Leighl, MD, MMSc
1.00 program credit
Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage III/IV Melanoma
Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage III/IV Melanoma
MinuteCE®
Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage III/IV Melanoma
1.00 program credit
- Paolo A. Ascierto, MD
- Hussein Tawbi, MD, PhD
1.00 program credit
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed Stage III Melanoma
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed Stage III Melanoma
MinuteCE®
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed Stage III Melanoma
1.00 program credit
- Paolo A. Ascierto, MD
- Hussein Tawbi, MD, PhD
1.00 program credit
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed BRAF-Mutant Stage IV Melanoma
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed BRAF-Mutant Stage IV Melanoma
MinuteCE®
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed BRAF-Mutant Stage IV Melanoma
1.00 program credit
- Hussein Tawbi, MD, PhD
- Sapna Patel, MD
1.00 program credit
Insights From Global Key Opinion Leaders on Regional Regulatory and Guideline Nuances to Optimize Melanoma Management
Insights From Global Key Opinion Leaders on Regional Regulatory and Guideline Nuances to Optimize Melanoma Management
MinuteCE®
Insights From Global Key Opinion Leaders on Regional Regulatory and Guideline Nuances to Optimize Melanoma Management
1.00 program credit
- Hussein Tawbi, MD, PhD
- Paolo A. Ascierto, MD
1.00 program credit

All Programs

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

All Programs

Popular

Title

Share on ReachMD

Welcome to the newGlobal Oncology Academy website.

Welcome to the new
Global Oncology Academy website.